Huron Consulting Group Inc. (NASDAQ:HURN) Shares Purchased by Ameriprise Financial Inc.

Ameriprise Financial Inc. boosted its holdings in Huron Consulting Group Inc. (NASDAQ:HURN) by 10.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 57,273 shares of the business services provider’s stock after buying an additional 5,187 shares during the quarter. Ameriprise Financial Inc. owned 0.32% of Huron Consulting Group worth $7,117,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Dakota Wealth Management lifted its stake in Huron Consulting Group by 4.0% in the fourth quarter. Dakota Wealth Management now owns 2,250 shares of the business services provider’s stock valued at $280,000 after acquiring an additional 87 shares during the last quarter. Summit Investment Advisors Inc. raised its holdings in Huron Consulting Group by 5.5% during the fourth quarter. Summit Investment Advisors Inc. now owns 1,838 shares of the business services provider’s stock valued at $228,000 after buying an additional 96 shares in the last quarter. Andina Capital Management LLC raised its holdings in Huron Consulting Group by 3.4% during the fourth quarter. Andina Capital Management LLC now owns 3,296 shares of the business services provider’s stock valued at $410,000 after buying an additional 107 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in Huron Consulting Group by 27.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 569 shares of the business services provider’s stock valued at $71,000 after buying an additional 122 shares in the last quarter. Finally, Hillsdale Investment Management Inc. raised its holdings in Huron Consulting Group by 0.5% during the fourth quarter. Hillsdale Investment Management Inc. now owns 34,060 shares of the business services provider’s stock valued at $4,232,000 after buying an additional 160 shares in the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

Analyst Upgrades and Downgrades

HURN has been the subject of several recent analyst reports. Benchmark reaffirmed a “buy” rating and set a $165.00 price objective on shares of Huron Consulting Group in a report on Wednesday, March 26th. William Blair reaffirmed an “outperform” rating on shares of Huron Consulting Group in a report on Wednesday, March 26th. Barrington Research upped their price objective on shares of Huron Consulting Group from $167.00 to $173.00 and gave the stock an “outperform” rating in a report on Monday, May 5th. Wedbush lifted their price target on Huron Consulting Group from $150.00 to $165.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 26th. Finally, Wall Street Zen downgraded Huron Consulting Group from a “buy” rating to a “hold” rating in a research report on Friday, May 2nd. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $170.75.

Insider Buying and Selling

In related news, Director John Mccartney sold 500 shares of the business’s stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $133.63, for a total transaction of $66,815.00. Following the transaction, the director now directly owns 51,621 shares in the company, valued at approximately $6,898,114.23. The trade was a 0.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director James H. Roth sold 8,641 shares of the firm’s stock in a transaction that occurred on Wednesday, March 26th. The shares were sold at an average price of $142.38, for a total value of $1,230,305.58. Following the completion of the sale, the director now directly owns 47,638 shares of the company’s stock, valued at approximately $6,782,698.44. The trade was a 15.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 76,239 shares of company stock worth $11,168,801. 2.15% of the stock is owned by insiders.

Huron Consulting Group Trading Up 0.1%

HURN opened at $150.69 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.61 and a quick ratio of 1.61. The company has a market cap of $2.60 billion, a price-to-earnings ratio of 32.76 and a beta of 0.23. The firm has a 50 day simple moving average of $143.99 and a 200 day simple moving average of $133.64. Huron Consulting Group Inc. has a fifty-two week low of $84.87 and a fifty-two week high of $155.00.

Huron Consulting Group (NASDAQ:HURN) last released its quarterly earnings data on Tuesday, April 29th. The business services provider reported $1.68 EPS for the quarter, beating analysts’ consensus estimates of $1.16 by $0.52. The business had revenue of $404.14 million during the quarter, compared to analysts’ expectations of $389.27 million. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The firm’s quarterly revenue was up 11.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.23 EPS. On average, sell-side analysts anticipate that Huron Consulting Group Inc. will post 6.1 earnings per share for the current year.

Huron Consulting Group Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.